Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies
Cancer Reports · 2024
DOI: 10.1002/cnr2.2103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Zhihui Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms, SARS-CoV-2. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In December 2022, a large‐scale epidemic occurred in China due to Omicron variant of SARS‐CoV‐2. This study explored risk factors for Omicron infection in transplant recipients at our institution and investigated the factors influencing the severity of SARS‐CoV‐2 Omicron infection among recipients of allo‐HSCT.
Methods
This single‐center study investigated totally 63 allogeneic hematopoietic stem cell transplant patients infected with Omicron variant at the Beijing GoBroad Boren Hospital Transplant Center during December 2022 and analyzed their risk factors.
Results
The study included 63 allogeneic hematopoietic stem cell transplant patients who developed Omicron infection. There were 34 mild and 29 moderate to severe cases. Their median age was 22 years (range, 1–65 years), with the male‐to‐female ratio being 1:1.1. Acute myeloid leukemia (53.97%), acute lymphoblastic leukemia (42.86%), and non‐Hodgkin lymphoma (3.17%) were underlying diseases. The median time between HCT and Omicron infection was 8.45 months. Significant predictive factors for moderate to severe Omicron infection included older age ( p < .0001), cGVHD ( p = .0195), concurrent bacterial infection ( p < .0001), low absolute lymphocyte count ( p = .026), low CD4/CD8 ratio ( p = .0091), high CRP ( p < .0001), high serum ferritin ( p = .0023), high D‐dimer ( p < .0001), low CD4 absolute count ( p = .0057), and low B‐cell absolute count ( p = .0154). A moderate to high HCT‐CI score tended to be associated with moderate to severe infection ( p = .0596).
Conclusion
This study indicates that risk factors for severe Omicron infection include certain clinical characteristics, such as age, cGVHD, and inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China.
- Department of Medical Laboratory, Beijing GoBroad Boren Hospital, Beijing, China.
- Gobroad Research Center, Gobroad Healthcare Group, Beijing, China.
ORCID-Profile: Tong Wu
Zitieren
APA
Li, Z., Wang, L., Zheng, Q., Xu, T., Yang, K., Wang, X., Wen, X., Zhang, C., Wang, J., Song, Y., Zhao, Y., Zheng, X., & Wu, T. (2024). Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies. Cancer Reports. https://doi.org/10.1002/cnr2.2103
Vancouver
Li Z, Wang L, Zheng Q, Xu T, Yang K, Wang X, et al. Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies. Cancer Reports. 2024. doi:10.1002/cnr2.2103
BibTeX
@article{Li2024,
author = {Li, Zhihui and Wang, Lei and Zheng, Qinlong and Xu, Teng and Yang, Keyan and Wang, Xianxuan and Wen, Xiaopei and Zhang, Caiyan and Wang, Jingjing and Song, Yanzhi and Zhao, Yongqiang and Zheng, Xiaoyu and Wu, Tong},
title = {Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.2103}
}
EUVIMED